Source link : https://www.newshealth.biz/health-news/insmeds-lung-disease-drug-succeeds-in-late-stage-study/
(Reuters) -Insmed said its drug candidate for a chronic lung disease helped significantly reduce the frequency of respiratory symptoms such as chronic cough in a late-stage study, prompting its shares to double in premarket trading on Tuesday. Data from 1,680 adult and 41 adolescent patients with non-cystic fibrosis bronchiectasis also showed the drug, brensocatib, was […]
Author : News Health
Publish date : 2024-05-28 10:53:54
Copyright for syndicated content belongs to the linked Source.